By

Luke Timmerman

23
Jan
2020

Much Ado About Coronavirus and 23andMe Hits the Wall

This was a quiet week in biopharma. Review it in your weekly Frontpoints. This Week in Alarmism Every year, we hear about an infectious disease scare that generates massive coverage, way out of proportion with the actual threat posed. Remember Mad Cow disease, SARS, Bird flu, Ebola, etc. etc? I’ve been in newsrooms providing saturation coverage of such things, and...
Read More
30
Dec
2019

Designer Proteins as Better Therapies: David Baker on The Long Run

Today’s guest on The Long Run is David Baker. David is a biochemistry professor at the University of Washington, a Howard Hughes Medical Institute investigator, and the director of The Institute for Protein Design at the University of Washington. Just like the name suggests, this institute works on designing proteins with special properties. Sometimes these proteins are designed on computers,...
Read More